CEO Dexter Tjoa shares insights on the company’s journey, from early barcoding breakthroughs to embracing advanced ...

At CPHI Milan 2024, Abzena showcased its latest innovations in cell line development and ADC manufacturing, featuring the advanced AbZelectPRO platform and ThioBridge linker technology.

The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...

Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.

A new case study released by AllazoHealth reveals that a leading rare disease pharmaceutical company achieved a 10.4% increase in therapy initiation, driven by AI-enabled patient outreach and ...

Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.

Innovative radiotherapy offers a precision treatment alternative.

Palomar Health Foundation ignites youth interest in healthcare with Middle School Medical Discoveries program.

Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.